The final project review was held in Brussells Jan 27th 2012. The project achieved the highest evaluation score “excellent” for all three reviews by the European Commission. The coordinator and project manager will warmly thank all beneficiaries and interest groups for their hard work and active collaboration in this excellent project. Our work for finding efficient biomarkers and developing clinical support systems for AD has been a great success and will continue.
PredictAD Alzheimer’s Disease Presenilin Research
Apolipoprotein E or APOE PCR testing on Amyloid Brain Tissue
